ELIZABETH SHPALL to Drug Evaluation
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Drug Evaluation.
Connection Strength
0.063
-
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. J Clin Oncol. 1991 Jan; 9(1):85-93.
Score: 0.023
-
Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Prog Clin Biol Res. 1990; 333:321-35; discussion 336.
Score: 0.021
-
The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer. Cancer. 1990 Aug 01; 66(3):431-6.
Score: 0.005
-
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol. 1988 Sep; 6(9):1368-76.
Score: 0.005
-
Recombinant human granulocyte-macrophage colony-stimulating factor produces fever. Lancet. 1988 Apr 23; 1(8591):950.
Score: 0.005
-
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med. 1988 Apr 07; 318(14):869-76.
Score: 0.005